Inovio prices $20M public offering of common stock and warrants

INOVIO PHARMACEUTICALS, INC.

Offering of 21,052,632 shares and warrants to purchase up to 42,105,264 shares at $1.10 exercise price.
Combined price $0.95 per share and warrant; gross proceeds $20M, net proceeds ~$18.3M.
Underwriter Piper Sandler; option exercised for additional warrants to buy 6,315,788 shares.
Closing expected on or about July 31, 2026, subject to customary conditions.
Proceeds intended for general corporate purposes; no specific use disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.